Paper32758477
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.
Johnson DB and 7 others. Lancet Oncol, 2020. Cited by 92 papers, by iCite.
Cite this record
ConductScience Library. Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research. Papers, record 32758477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32758477
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Immunological | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Medical Oncology | |
| Patient Care | |
| Patient Education as Topic |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 CA204726 | NCI NIH HHS | United States | K23CA204726 | PubMed and NIH | NIH RePORTER |
| R01 CA227481 | NCI NIH HHS | United States | R01CA227481 | PubMed and NIH | NIH RePORTER |
| K23 AR075872 | NIAMS NIH HHS | United States | K23AR075872 | PubMed and NIH | NIH RePORTER |
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985639 | Long non-coding RNA prompts immune-related adverse events risk and immunotherapy response in pan-cancer. | iScience | 2026 | https://conductscience.org/library/papers/42985639 | PubMed |
| 42973799 | Exploring real-world unmet clinical needs among patients on first-line treatment with HER2-negative advanced gastric, gastroesophageal junction or esophageal adenocarcinoma in Asia, Europe and the United States. | Front Oncol | 2026 | https://conductscience.org/library/papers/42973799 | PubMed |
| 42886418 | Exploring uncertainties in melanoma management: a Spanish multidisciplinary Delphi consensus. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42886418 | PubMed |
| 42780081 | Immune checkpoint inhibitor-related thyroid dysfunction during treatment of lung cancer: a disproportionality analysis based on the FDA adverse event reporting system. | Front Immunol | 2026 | https://conductscience.org/library/papers/42780081 | PubMed |
| 42759982 | CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42759982 | PubMed |
| 42721039 | B cell-guided inflammatory cascade perpetuates ICI-mediated colitis. | Cell Rep | 2026 | https://conductscience.org/library/papers/42721039 | PubMed |
| 42496605 | Pharmacovigilance Evaluation of Noninfectious Myocarditis and Pericarditis in Immune Checkpoint Inhibitor Recipients Using FAERS. | Technol Cancer Res Treat | 2026 | https://conductscience.org/library/papers/42496605 | PubMed |
| 41483376 | Immune checkpoint blockade in cancer: current insights and future horizons. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41483376 | PubMed |
| 41357215 | Beyond monotherapy: multimodal strategies integrating immune checkpoint inhibitors in lymphoma management. | Front Immunol | 2025 | https://conductscience.org/library/papers/41357215 | PubMed |
| 41084760 | User-centered design of a COPD care pathway for patients with cancer: a mixed-methods clinical trial protocol. | Future Oncol | 2025 | https://conductscience.org/library/papers/41084760 | PubMed |
| 40949101 | Evolving tumor microenvironment: Driving cancer initiation and progression in cardiovascular diseases. | iScience | 2025 | https://conductscience.org/library/papers/40949101 | PubMed |
| 40900883 | Asymptomatic Troponin Elevation and Early Mortality Following Immune Checkpoint Inhibitor Therapy in Patients Without Cardiac Adverse Events. | Cancer Diagn Progn | 2025 | https://conductscience.org/library/papers/40900883 | PubMed |
| 40865971 | Efficacy and safety of immunotherapy in anaplastic thyroid carcinoma: a systematic review and meta-analysis. | Int J Surg | 2026 | https://conductscience.org/library/papers/40865971 | PubMed |
| 40752492 | Cardiometabolic disease and cardio-oncology: Insights from iPSC models and tissue engineering. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40752492 | PubMed |
| 39583866 | Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors: Data From a Prospective Study. | JACC Adv | 2024 | https://conductscience.org/library/papers/39583866 | PubMed |
| 39578288 | Clinical and histopathological features of immune checkpoint inhibitor-induced lung toxicity. | Virchows Arch | 2025 | https://conductscience.org/library/papers/39578288 | PubMed |
| 39489880 | Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review. | Br J Cancer | 2025 | https://conductscience.org/library/papers/39489880 | PubMed |
| 39254897 | Troponin Elevation in Asymptomatic Cancer Patients: Unveiling Connections and Clinical Implications. | Curr Heart Fail Rep | 2024 | https://conductscience.org/library/papers/39254897 | PubMed |
| 39062138 | Immunomodulating and Immunosuppressive Therapy for Virus-Negative Immune-Mediated Myocarditis. | Biomedicines | 2024 | https://conductscience.org/library/papers/39062138 | PubMed |
| 38982146 | Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart. | Nat Rev Cancer | 2024 | https://conductscience.org/library/papers/38982146 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32758477
GET https://conductscience.org/api/papers/v1/32758477/cited_by?page=2